Cargando…
The use of anti-tuberculosis therapy for latent TB infection
Tuberculosis infection is of global public health significance, with millions of incident cases each year. Many cases, particularly in low-prevalence settings, result from the reactivation of latent tuberculosis infection (LTBI); potentially acquired years prior to active disease. Up to one-third of...
Autores principales: | Denholm, Justin T, McBryde, Emma S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108738/ https://www.ncbi.nlm.nih.gov/pubmed/21694895 |
Ejemplares similares
-
Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice
por: Denholm, Justin T., et al.
Publicado: (2010) -
Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study
por: Denholm, Justin T, et al.
Publicado: (2014) -
A novel Bayesian geospatial method for estimating tuberculosis incidence reveals many missed TB cases in Ethiopia
por: Shaweno, Debebe, et al.
Publicado: (2017) -
The role of geospatial hotspots in the spatial spread of tuberculosis in rural Ethiopia: a mathematical model
por: Shaweno, Debebe, et al.
Publicado: (2018) -
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)